Adam Keeney
Corporate Officer/Principal presso BIOGEN INC.
Patrimonio netto: 153 465 $ in data 30/06/2024
Profilo
Adam Keeney is currently the Executive VP & Head-Corporate Development at Biogen, Inc. Prior to this, he worked as the President, Chief Executive Officer & Director at NodThera Ltd.
He completed his undergraduate degree at the University of Leeds and his doctorate at The University of Nottingham.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOGEN INC.
0.00% | 01/05/2024 | 662 ( 0.00% ) | 153 465 $ | 30/06/2024 |
Posizioni attive di Adam Keeney
| Società | Posizione | Inizio |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 17/04/2023 |
Precedenti posizioni note di Adam Keeney
| Società | Posizione | Fine |
|---|---|---|
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Amministratore Delegato | - |
Formazione di Adam Keeney
| The University of Nottingham | Doctorate Degree |
| University of Leeds | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Adam Keeney
